Adding Value to Drug Development Utilizing Spatial Bioanalysis: A Case Study
Join scientists, from both companies, for a live webinar to learn more about this major milestone.
You will discover how spatial bioanalysis adds value to the drug development process by building robust data to assess risk/benefit profiles and drive strategic decisions regarding their pipelines, including how to:
- Generate a hypothesis based on the weight of evidence
- Support the accelerated timelines for market authorization of sotorasib
- Investigate renal toxicity in the rat